Cormedix Analyst Ratings
Cormedix Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Beam Therapeutics (BEAM), Cormedix (CRMD) and Applied Therapeutics (APLT)
Analysts' Top Healthcare Picks: Cormedix (CRMD), SCYNEXIS (SCYX)
Truist Financial Reaffirms Their Buy Rating on Cormedix (CRMD)
Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Evolent Health (EVH) and Cormedix (CRMD)
Truist Financial Remains a Buy on Cormedix (CRMD)
Cormedix Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Shandong Weigao Group Medical Polymer Co (OtherSHWGF) and Cormedix (CRMD)
Cormedix Analyst Ratings
RBC Capital Remains a Buy on Cormedix (CRMD)
Analysts Offer Insights on Healthcare Companies: Cencora (COR), Cormedix (CRMD) and NeueHealth Inc (NEUE)
Cormedix Analyst Ratings
Buy Rating on Cormedix Amidst DefenCath Launch and Strong Financial Positioning
Analysts Are Bullish on These Healthcare Stocks: Cormedix (CRMD), PROCEPT BioRobotics (PRCT)
Cormedix Analyst Ratings
Buy Rating Affirmed: Cormedix's DefenCath Poised for Success With Positive Reimbursement Outlook and Strategic Launch Plan
RBC Capital Maintains Outperform on Cormedix, Raises Price Target to $10
JMP Securities Reiterates Market Outperform on Cormedix, Maintains $19 Price Target
Cormedix Analyst Ratings